A detailed history of Mariner, LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Mariner, LLC holds 9,269 shares of TYRA stock, worth $134,585. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,269
Previous 10,785 14.06%
Holding current value
$134,585
Previous $172,000 26.16%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$16.7 - $24.36 $25,317 - $36,929
-1,516 Reduced 14.06%
9,269 $217,000
Q2 2024

Aug 13, 2024

BUY
$14.45 - $20.22 $155,843 - $218,072
10,785 New
10,785 $172,000
Q4 2023

Feb 14, 2024

SELL
$11.01 - $14.95 $23,473 - $31,873
-2,132 Reduced 8.78%
22,164 $306,000
Q3 2023

Nov 13, 2023

BUY
$13.15 - $16.08 $35,807 - $43,785
2,723 Added 12.62%
24,296 $334,000
Q2 2023

Aug 11, 2023

BUY
$11.99 - $17.51 $527 - $770
44 Added 0.2%
21,573 $367,000
Q1 2023

May 12, 2023

BUY
$6.85 - $16.22 $147,473 - $349,200
21,529 New
21,529 $346,000

Others Institutions Holding TYRA

About Tyra Biosciences, Inc.


  • Ticker TYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,973,600
  • Market Cap $609M
  • Description
  • Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...
More about TYRA
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.